
Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
Published on March 10, 2026
The FDA ultimately ruled against approving leucovorin for autism, citing a lack of "sufficient data."

The FDA ultimately ruled against approving leucovorin for autism, citing a lack of "sufficient data."